Microbiology & Infectious Diseases

A Phase IIb clinical trial evaluating the tuberculosis vaccine H56:IC31 has found no evidence that it reduces the risk of recurrent disease in individuals who have completed treatment for pulmonary tuberculosis.

The new guidelines address emerging antifungal resistance, recent taxonomic reclassifications, and gaps in existing treatment recommendations.

Findings reveal alarmingly high rates of AMR among bacterial pathogens affecting patients with cancer worldwide.

New research highlights the role of ventilator-capable nursing homes in the spread of antimicrobial-resistant pathogens, including the emerging multidrug-resistant fungus Candida auris.

Persistent fever beyond 72 hours in patients with methicillin-resistant Staphylococcus aureus bacteraemia is strongly associated with increased mortality.

Children exposed to HIV and antiretroviral (ARV) treatments during pregnancy face a higher risk of developing neurodevelopmental disorders, according to recent French study.

Machine learning identifies key genes and potential treatments for sepsis, improving diagnosis and offering new therapeutic targets.

Findings revealed that microbiota maturation in cystic fibrosis is delayed, preventing the establishment of a stable, adult-like community.